Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Research Partnership is expanding its US capabilities with new offices opening in San Francisco and New York

May 2, 2017 | Expansion, New York, San Francisco, USA 

Research Partnership is today expanding its US operations across both the West and East Coast. Director Tom Winter has relocated from London and is today opening a new office in San Francisco, to better service West Coast clients.

Research Partnership is today expanding its US operations across both the West and East Coast. Director Tom Winter has relocated from London and is today opening a new office in San Francisco, to better service West Coast clients. 

Director Rachel Howard is opening a new office in New York to continue to build our emerging markets business and to provide a US hub for our syndicated business. Both Directors will manage a team of researchers and are actively recruiting for additional staff at each of these sites. The two new offices, and the regional office in Boston, complement the company’s US Headquarters in Philadelphia which is led by President Harriet Kozak.  

Tom Winter is supported by Associate Director Birgit Eschmann and Research Manager Will Simpson. Michelle Toennies, Senior Research Executive and Rebecca D’Orazio, Research Executive are both relocating from the Philadelphia office. In addition, two local graduates will be joining the team in June.   

Rachel is supported by Fara Mboge, Head of Business Development, Syndicated and Tracking services and Alyssa Pritchard, Senior Research Executive. Two local graduates will also be joining the New York team in June.  

Commenting on the expansion, Mary Assimakopoulos, Founding Director, said, “Research Partnership is celebrating its 20th anniversary this year. We have become one of the largest independent global healthcare market research agencies and our further expansion in the US is in line with our key objective for achieving continued growth in this key market.”

Visit researchpartnership.com to find out more.

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

The risk of replicating social bias in synthetic patient data – The need for human intelligence partnered with AI

Authored by Paul Reed and Anabelle Gall

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Product launch: What market research when?

Get the insights you need, when you need them, for your product launch planning

Therapy Watch launches new tracker covering Alzheimer’s Disease

The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.

Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.

Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

Authored by: Constanza Salas, Jhon Galindo and Rachel Howard

Therapy Watch launches new tracker covering Postpartum Depression

The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry